Research Area: High-throughput and high-content serology

JSON
CSV
XLSX
TXT

Primary: Shown in the list of current labels.

Year 2022

PubMed DOI Crossref
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.
Laurén I, Havervall S, Ng H, ..., Thålin C, Mangsbo S
Immun Inflamm Dis 10 (4) e595 [2022-04-00; online 2022-03-30]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Research Area: Vaccine Type: Journal article
PubMed DOI Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U, Havervall S, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines 10 (3) 359 [2022-02-24; online 2022-02-24]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S, Jernbom Falk A, Klingström J, ..., Nilsson P, Thålin C
PLoS One 17 (1) e0262169 [2022-01-12; online 2022-01-12]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C
J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution
DOI Crossref
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
Havervall S, Marking U, Greilert‐Norin N, ..., Åberg M, Thålin C
Clin Transl Immunol 11 (4) - [2022-01-00; online 2022-04-18]
Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Type: Journal article

Year 2021

DOI Crossref
Influenza A H1N1–mediated pre-existing immunity to SARS-CoV-2 predicts COVID-19 outbreak dynamics
Almazán NM, Rahbar A, Carlsson M, ..., Sörensen B, Söderberg-Nauclér C
medRxiv - (-) - [2021-12-25; online 2021-12-25]
Category: Genomics & transcriptomics Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Preprint
PubMed DOI Crossref
Differences in risk for SARS-CoV-2 infection among healthcare workers
Elfström KM, Blomqvist J, Nilsson P, ..., Lundgren KC, Dillner J
Prev Med Rep 24 (-) 101518 [2021-12-00; online 2021-12-00]
Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care.
Klevebro S, Bahram F, Elfström KM, ..., Dillner J, Melén E
Scand J Public Health 49 (7) 707-712 [2021-11-00; online 2021-06-19]
Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies.
Mravinacova S, Jönsson M, Christ W, ..., Månberg A, Hober S
N Biotechnol 66 (-) 46-52 [2021-10-07; online 2021-10-07]
Category: Biochemistry Category: Health Funder: H2020 Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.
Blixt L, Bogdanovic G, Buggert M, ..., Hansson L, Österborg A
Leukemia - (-) - [2021-09-25; online 2021-09-25]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Asplund Högelin K, Ruffin N, Pin E, ..., Piehl F, Al Nimer F
iScience 24 (9) 103078 [2021-09-00; online 2021-09-00]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Research Area: Vaccine Type: Journal article
DOI Crossref
Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Havervall S, Marking U, Gordon M, ..., Hober S, Thålin C
MedRxiv - (-) - [2021-08-12; online 2021-08-12]
Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Preprint
PubMed DOI Crossref
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
Alkharaan H, Bayati S, Hellström C, ..., Pin E, Sällberg Chen M
The Journal of Infectious Diseases 224 (3) 407-414 [2021-08-02; online 2021-05-13]
Category: Health Funder: H2020 Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.
Havervall S, Marking U, Greilert-Norin N, ..., Åberg M, Thålin C
EBioMedicine 70 (-) 103523 [2021-08-00; online 2021-08-12]
Category: Drug Discovery Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S, Hellström C, Olofsson J, ..., Hedhammar M, Nilsson P
Clin Transl Immunol 10 (7) e1312 [2021-07-19; online 2021-07-19]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
Dillner J, Elfström KM, Blomqvist J, ..., Arroyo Mühr LS, Lundgren KC
The Journal of Infectious Diseases 224 (1) 14-20 [2021-07-02; online 2021-02-14]
Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2.
Roxhed N, Bendes A, Dale M, ..., Fredolini C, Schwenk JM
Nat Commun 12 (1) 3695 [2021-06-17; online 2021-06-17]
Category: Health Category: Serology Funder: H2020 Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 in hospital indoor environments is predominantly non-infectious.
Krambrich J, Akaberi D, Ling J, ..., Hagbom M, Lundkvist Å
Virol J 18 (1) 109 [2021-06-02; online 2021-06-02]
Category: Biochemistry Category: Health Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2.
Hoffman T, Kolstad L, Rönnberg B, Lundkvist Å
Viruses 13 (6) - [2021-05-31; online 2021-05-31]
Category: Biochemistry Category: Health Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
Hoffman T, Kolstad L, Lindahl JF, ..., Rönnberg B, Lundkvist Å
Viruses 13 (6) - [2021-05-26; online 2021-05-26]
Category: Biochemistry Category: Other Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms
Cunningham JL, Virhammar J, Rönnberg B, ..., Karlsson Hedestam GB, Rostami E
The Journal of Infectious Diseases - (-) - [2021-03-21; online 2021-03-21]
Category: Biochemistry Category: Health Category: Proteins Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
Sherina N, Piralla A, Du L, ..., Marcotte H, Pan-Hammarström Q
Med (N Y) 2 (3) 281-295.e4 [2021-03-12; online 2021-02-10]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Antibodies to SARS-CoV-2 and risk of past or future sick leave.
Dillner J, Elfström KM, Blomqvist J, ..., Mühr LSA, Conneryd Lundgren K
Sci Rep 11 (1) 5160 [2021-03-04; online 2021-03-04]
Category: Health Category: Proteins Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Functional myeloid-derived suppressor cells expand in blood but not airways of COVID-19 patients and predict disease severity
Falck-Jones S, Vangeti S, Yu M, ..., Farnert A, Smed-Sorensen A
J Clin Invest 131 (6) - [2021-01-28; online 2021-01-25]
Category: Health Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Nursing students' experiences of a pedagogical transition from campus learning to distance learning using digital tools.
Langegård U, Kiani K, Nielsen SJ, Svensson P
BMC Nurs 20 (1) 23 [2021-01-19; online 2021-01-19]
Category: Public Health Research Area: High-throughput and high-content serology Type: Journal article

Year 2020

PubMed DOI Crossref
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
Marklund E, Leach S, Axelsson H, ..., Liljeqvist JÅ, Gisslén M
PLoS One 15 (10) e0241104 [2020-10-21; online 2020-10-21]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Biomarkers and systems immunology Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
Rudberg AS, Havervall S, Månberg A, ..., Hober S, Thålin C
Nat Commun 11 (1) 5064 [2020-10-08; online 2020-10-08]
Category: Health Category: Serology Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
SciLifeLab Data Centre
Publications 9.5.1